WallStSmart
NXGL

Nexgel Inc

NASDAQ: NXGL · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$0.59
-1.63% today

Updated 2026-04-30

Market cap
$5.14M
P/E ratio
P/S ratio
0.45x
EPS (TTM)
$-0.38
Dividend yield
52W range
$1 – $3
Volume
0.4M

Nexgel Inc (NXGL) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2016201720182019202020212022202320242025
Revenue$2.15M$1.99M$2.21M$717000.00$674000.00$1.55M$2.05M$4.09M$8.69M$11.42M
Revenue growth (YoY)-7.4%+11.1%-67.6%-6.0%+130.1%+32.0%+99.7%+112.5%+31.5%
Cost of revenue$2.27M$1.84M$1.70M$854000.00$965000.00$1.54M$1.79M$3.71M$5.94M$6.91M
Gross profit$-114000.00$147000.00$514000.00$-137000.00$-291000.00$8000.00$256000.00$374000.00$2.75M$4.51M
Gross margin-5.3%7.4%23.2%-19.1%-43.2%0.5%12.5%9.1%31.6%39.5%
R&D$0.00$31000.00$367000.00$103000.00$78000.00$2000.00
SG&A$2.40M$1.79M$1.96M$2.08M$2.38M$2.96M$3.69M$7.86M
Operating income$-1.86M$-969000.00$-1.89M$-1.92M$-2.26M$-2.57M$-3.35M$-3.48M$-3.55M$-3.35M
Operating margin-86.6%-48.6%-85.3%-268.3%-335.3%-165.7%-163.5%-85.0%-40.9%-29.3%
EBITDA$-1.54M$-653000.00$-1.57M$-1.86M$-2.20M$-2.17M$-3.11M$-2.73M$-2.90M$-2.12M
EBITDA margin-71.6%-32.8%-70.8%-259.0%-327.0%-140.2%-151.8%-66.8%-33.4%-18.6%
EBIT$-1.86M$-969000.00$-1.89M$-1.92M$-2.25M$-2.31M$-3.41M$-3.17M$-3.38M$-2.86M
Interest expense$0.00$0.00$1000.00$10000.00$2.00M$1.34M$15000.00$81000.00$34000.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-1.78M$-953000.00$-1.89M$-1.92M$-2.26M$-4.31M$-4.75M$-3.16M$-3.28M$-3.00M
Net income growth (YoY)+46.3%-98.1%-1.9%-17.7%-90.4%-10.1%+33.5%-3.9%+8.6%
Profit margin-82.5%-47.8%-85.3%-268.2%-335.9%-277.9%-231.7%-77.2%-37.8%-26.3%